Hutchin Hill Capital, LP - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 53.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hutchin Hill Capital, LP ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$935,000
-18.9%
91,200
+3.3%
0.02%
-51.3%
Q2 2016$1,153,000
+137.2%
88,300
+99.9%
0.04%
+178.6%
Q1 2016$486,000
-36.0%
44,170
-42.9%
0.01%
-30.0%
Q2 2015$759,000
+20.7%
77,300
+8.9%
0.02%
+17.6%
Q1 2015$629,000
+208.3%
71,000
+139.9%
0.02%
+112.5%
Q3 2014$204,00029,6000.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sensato Investors LLC 1,564,682$10,859,0002.03%
Matarin Capital Management, LLC 274,291$1,903,580,0000.39%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 87,524$607,417,0000.36%
TFS CAPITAL LLC 323,415$2,245,0000.22%
Nantahala Capital Management 170,218$1,181,0000.16%
Ativo Capital Management LLC 74,338$592,0000.16%
MENTA CAPITAL LLC 111,985$777,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 229,891$1,595,0000.11%
GSA CAPITAL PARTNERS LLP 270,888$1,880,0000.09%
BOOTHBAY FUND MANAGEMENT, LLC 25,644$178,0000.08%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders